ArticleHaematologica2025

Letermovir prophylaxis for cytomegalovirus is associated with risk of post-transplant lymphoproliferative disorders after haploidentical stem cell transplantation.

Xu-Ying Pei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.